Nebius, Stock

Nebius Stock: A 571% Sales Surge, a $27 Billion Capex Bill, and a 2027 Deadline That Now Does the Grading

Published on 11/16/2026 at 15:10 | Editorial boerse-global.de
Nebius cut its 2026 revenue guidance to the low end and raised capex to about $27 billion as third-party data center delays push capacity into 2027.
Nebius Stock: A 571% Sales Surge, a $27 Billion Capex Bill, and a 2027 Deadline That Now Does the Grading Illustration mit AI erstellt.

Nebius has a growth story most infrastructure companies would envy. It also has a delivery schedule that no longer belongs entirely to Nebius.

That tension is what investors are pricing right now. The company said on Thursday that delays at third-party data centers will push a chunk of its capacity — and the revenue attached to it — into the first half of 2027. The same day, it guided full-year 2026 revenue to the low end of a $3.0 billion to $3.4 billion range and lifted its 2026 capital expenditure plan to roughly $27 billion, up from a prior $20 billion to $25 billion band.

The stock's reaction has been sharp. Shares were down 8.4% at one point in the session, and the day's move stood at -4.7% as the picture settled.

What the third quarter actually showed

Strip out the forward-looking noise and the trailing numbers are striking. Nebius reported third-quarter 2026 revenue of $980.8 million, a 571% increase year over year.

Should investors sell immediately? Or is it worth buying Nebius?

That figure matters because it establishes what is already working. The business has scaled fast, and the case for owning the equity has never rested on a promise alone. But a 571% growth rate also raises the bar: the next leg has to come from capacity that is not yet switched on, and the timing of that switch-on has now slipped.

Three brokers, three targets, zero downgrades

Friday brought a cluster of analyst revisions, and the pattern is more interesting than any single number.

Bank of America cut its price target to $265 from $310 while keeping a Buy rating. Baird, according to media reports, halved its target to $200 from $340 and stayed at Outperform. D.A. Davidson went further on the valuation side, slashing its target to $125 from $250, but held at Neutral — citing the data center delays and a weaker outlook for the run-rate revenue level.

Read the three together and the message is not a wholesale retreat from the growth thesis. It is a repricing of when that growth arrives. A lower target and an unchanged rating can coexist; they describe the same company at two different points on a timeline.

What the revisions do not do is justify a decision on their own. The reasoning behind each cut is what carries weight, and the reasoning differs: some houses treat the slippage as a timing issue, others as evidence of a higher execution risk that deserves a permanently lower multiple.

The distinction that decides the outcome

Deferred revenue is not recovered revenue. That single sentence is the whole investment debate in miniature.

If the third-party capacity arrives as now scheduled, the associated sales should follow, and the question for shareholders becomes one of duration rather than viability. If further slippage piles up, the problem stops being a date on a calendar and becomes a question about how much confidence the planning process itself deserves.

The optimistic reading draws some support from the fact that no house walked away from its positive stance. It draws none from the idea that a recovery is imminent — a lower target paired with a Buy is not a signal, it is a range of outcomes.

Capex and timing pull in opposite directions

Thursday's raised spending plan sharpens the pressure. Committing to as much as $27 billion for 2026 while a portion of the capacity it funds becomes available later is a more demanding combination than either fact alone.

Nebius at a turning point? This analysis reveals what investors need to know now.

Higher outlays do not by themselves prove faster expansion. Their value depends on whether the infrastructure can be put to work on schedule, and on that front Nebius is partly dependent on external data center providers — a dependency that limits its direct control over the timetable in exactly the cases now in question.

None of this establishes a funding gap. It does mean investors should weight timing more heavily: when do the planned investments turn into usable capacity, and when does that capacity turn into revenue?

First-half 2027 is the exam

The next concrete operational checkpoint is the delivery of the capacity Nebius says has moved into 2027. Progress there would carry more information than a restatement of long-term growth ambitions. Fresh delays would weaken the timing thesis and force a harder look at whether expectations match the actual pace of build-out.

For now, the stock is caught between a genuinely exceptional growth record and a schedule it does not fully control. A cheaper valuation does not remove the execution risk. Only delivery can show whether this is a delay or something longer-lasting.

Ad

Nebius Stock: New Analysis - 16 November

Fresh Nebius information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated Nebius analysis...

Disclaimer...
en | NL0009805522 | NEBIUS | boerse | 70521184 |